Cadence Pharma Seeks Approval Of IV Fever Drug

SAN DIEGO (AP) ¿ Cadence Pharmaceuticals Inc. said Thursday it asked the Food and Drug Administration to approve its drug candidate Acetavance, a form of the painkiller acetaminophen that is given intravenously.

Cadence filed a New Drug Application with the FDA, formally requesting marketing approval for Acetavance as a treatment for acute pain and fever. The San Diego, Calif., company said that Acetavance would be the only intravenous drug approved to treat fever, and the first new intravenous painkiller approved in more than 20 years, pending the FDA's ruling.

In morning trading, Cadence shares gained 25 cents, or 2.6 percent, to $9.75.

Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

More from Food & Drink

Will Kraft Heinz Buy Pepsico or Mondelez?

Will Kraft Heinz Buy Pepsico or Mondelez?

Starbucks Sets Latest Plan to Recaffeinate Shares

Starbucks Sets Latest Plan to Recaffeinate Shares

Discount Retailers May Take Hit With Fewer Americans on Food Stamps

Discount Retailers May Take Hit With Fewer Americans on Food Stamps

Kellogg Issues Recall of Honey Smacks Cereal Amid Salmonella Outbreak

Kellogg Issues Recall of Honey Smacks Cereal Amid Salmonella Outbreak

Subway Rolling Back Breakfast Offerings

Subway Rolling Back Breakfast Offerings